Charles Schwab Investment Management »

Xeris Pharmaceuticals shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 403k 2.85
2024-06-30 $910k 405k 2.25
2024-03-31 $810k 366k 2.21
2023-12-31 $856k 364k 2.35
2023-09-30 $679k 365k 1.86
2023-06-30 $956k 365k 2.62
2023-03-31 $611k 375k 1.63
2022-12-31 $463k 348k 1.33
2022-09-30 $528k 338k 1.56
2022-06-30 $522k 338k 1.54
2022-03-31 $122k 48k 2.57
2021-12-31 $197k 67k 2.94